PE
1988
$3 000 M
Boston, Massachusetts, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Founded in 1988, Ampersand is a middle-market private equity firm with $3 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, Amsterdam and London, Ampersand leverages its unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors.
Consistent with our theme of increasing specialization as a source of differentiated performance, Ampersand’s Healthcare portfolio has been focused around several overlapping industry clusters where our multiple prior successes give us a competitive edge. Most of our portfolio companies have revenues between $10 and $200 million at the time of Ampersand’s investment. We typically invest between $10 and $200 million and years of operational expertise to drive each investment toward success.
Ampersand’s team has decades of operating experience in Healthcare companies and over 150 years of shared private equity experience. Our unusual combination of skills, including deep industry, technical, financial, operating, and transactional capabilities, make us a preferred partner for entrepreneurs because we can contribute to their success on multiple levels.
At our roots, we are company-builders, not investment managers. Our experience gives us empathy for our CEOs and helps us understand the challenges they face. This ability to identify, and contribute to, problem resolution makes us very effective in our companies.
Industry
Region of investment
Ampersand Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Ampersand 2014 Limited Partnership
|
Venture Capital (VC)
|
Healthcare Services
Marketing and Advertising
Media and Entertainment
Software
Telecommunications
HealthTech
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$110 M
|
March 2014
|
|
Ampersand 2018 Limited Partnership
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Software
Telecommunications
HealthTech
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$450 M
|
March 2018
|
|
Ampersand 2022 Limited Partnership
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
HealthTech
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$1200 M
|
August 2022
|
|
Ampersand 2026 (“AMP-26”) Limited Partnership
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Software
Telecommunications
HealthTech
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$1500 M
|
May 2026
|